Pitalia Capital
Pitalia Capital is a Bolton-based private family office investment vehicle founded in July 2021 by Anil Pitalia, entrepreneur and founder of SpaMedica (sold to Nordic Capital for approximately GBP 300m). The firm deploys proprietary balance-sheet capital, targeting UK SMEs with initial tickets of GBP 1m to GBP 10m across healthcare, manufacturing and consumer sectors. It launched with a GBP 50m direct-investment vehicle (no external LPs) managed by Managing Partner John Davies, formerly of Seneca Partners. The firm is registered at Companies House under number 13571349 and has no FCA AIFM authorisation as it invests own capital only.
Key facts
Recent exits
Coverage notes
1 fund tracked, 5 portfolio companies (4 active · 1 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Pitalia Capital has raised, with its portfolio companies. Hand-checked from public filings.
Pitalia Capital Balance Sheet FundBalance Sheet2021 · 5yr€59M4 active · 1 realized
Unrealized
4 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| AI-Sight | MedTech | UK | 2024 |
| Brass Monkey | Consumer | UK | 2023 |
| Chemist4U | HealthTech | UK | 2023 |
| Greenleaf House Group | Healthcare | UK | 2023 |
Realized
1 exit| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| CCM Motorcycles | Industrials | UK | 2021 | 2025 | Liquidation | – | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Pitalia Capital
Pitalia Capital Limited is a UK family-office private equity investor headquartered in Bolton, Greater Manchester, in the North West region of the United Kingdom. The firm was founded in 2019 with a public launch of the Pitalia Capital brand in July 2021. The firm sits within the broader Pitalia group of companies (Pitalia Real Estate, Pitalia Capital) founded by entrepreneur Anil Pitalia. Assets under management as of December 2024 are not formally disclosed; the firm launched with an initial GBP 50 million fund deploying private family-office capital. The structure is a family office (single-family office structure deploying proprietary Pitalia family capital) rather than an institutional LP-backed PE fund. There is a single family-office investment pool with no discrete fund vehicles in the institutional sense. Managing Partner is John Davies (formerly of Seneca Partners).
Investment thesis
Pitalia Capital pursues a mixed PE strategy combining early-stage growth capital alongside management buyouts of mid-sized firms, with long-hold flexible structuring not constrained by typical 4 to 7-year institutional fund cycles given the family-office capital base. Sector focus is sector-agnostic with declared in-house operational expertise in healthcare and wellness and in manufacturing. Confirmed portfolio sectors include healthcare distribution, specialist manufacturing, AI and healthcare diagnostics, and elder and disabled care. Geographic scope is UK-wide with particular emphasis on the North West region. Ticket size is GBP 1 million to GBP 10 million initial cheque per transaction with flexibility for larger commitments or follow-on rounds. The capital base is wholly funded by the Pitalia family with no third-party institutional LPs. Value creation operates through long-term flexible holding periods unconstrained by institutional fund deadlines, strategic and financial investment with founder and management alignment as primary screen, and active operational support drawn from group capabilities across real-estate and operating businesses.
Recent activity
Recent investments include AI-Sight in healthcare and diagnostic equipment AI (Seed, October 2024), Chemist4U in healthcare distribution (September 2023, GBP 12 million investment in parent), CCM Motorcycles in specialist manufacturing covering specialist motorcycles (2022 to 2023, Bolton-based) and Greenleaf in healthcare covering elder and disabled care. Recent exits include CCM Motorcycles in specialist manufacturing (August 2025). The platform continues to deploy family-office capital across UK SME private equity opportunities in healthcare, manufacturing and adjacent sectors with particular concentration in the North West region. Detailed buyer names and multiple data available on Pro at €29/month.
Investment team
Senior partners. Hand-checked from public filings and the firm's own site.
Similar firms
Other private equity firms tracked on GP Intel.